Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression
Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chron...
Saved in:
Published in | Journal of molecular and cellular cardiology Vol. 135; pp. 10 - 21 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chronic kidney disease (CKD) is not fully understood.
We used human vascular smooth muscle cells (VSMCs) and a rat model of chronic renal failure (CRF), and observed a native protective mechanism by which VC is reduced via the activation of Wnt1 and its transcriptional target ANKH inorganic pyrophosphate transport regulator (ANKH) gene. ANKH is an essential calcification inhibitor that effluxes inorganic pyrophosphate (PPi) from VSMCs to play an inhibitory role in VC. Vascular ANKH and plasma PPi were significantly downregulated in the rat model of CRF. The knockdown or inhibition of ANKH reversed the effect of Wnt1 on VC in VSMCs. Clinical analysis revealed low plasma levels of Wnt1 and PPi were associated with CKD in patients. Applying a Wnt/β-catenin signaling agonist can alleviate the progression of VC.
This work reveals the ANKH regulation of Wnt1 in VSMCs is essential for blocking VC. Our findings may contribute to the development of medications that target Wnt signaling and/or ANKH to inhibit VC.
•Novel mechanism of Wnt1 protects against vascular calcification.•ANKH, a vascular calcification inhibitor, is a target gene of Wnt1/β-catenin signal.•Agonist of Wnt/β-catenin signal is a potential medicine for vascular calcification. |
---|---|
AbstractList | Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chronic kidney disease (CKD) is not fully understood.
We used human vascular smooth muscle cells (VSMCs) and a rat model of chronic renal failure (CRF), and observed a native protective mechanism by which VC is reduced via the activation of Wnt1 and its transcriptional target ANKH inorganic pyrophosphate transport regulator (ANKH) gene. ANKH is an essential calcification inhibitor that effluxes inorganic pyrophosphate (PPi) from VSMCs to play an inhibitory role in VC. Vascular ANKH and plasma PPi were significantly downregulated in the rat model of CRF. The knockdown or inhibition of ANKH reversed the effect of Wnt1 on VC in VSMCs. Clinical analysis revealed low plasma levels of Wnt1 and PPi were associated with CKD in patients. Applying a Wnt/β-catenin signaling agonist can alleviate the progression of VC.
This work reveals the ANKH regulation of Wnt1 in VSMCs is essential for blocking VC. Our findings may contribute to the development of medications that target Wnt signaling and/or ANKH to inhibit VC.
•Novel mechanism of Wnt1 protects against vascular calcification.•ANKH, a vascular calcification inhibitor, is a target gene of Wnt1/β-catenin signal.•Agonist of Wnt/β-catenin signal is a potential medicine for vascular calcification. Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chronic kidney disease (CKD) is not fully understood. We used human vascular smooth muscle cells (VSMCs) and a rat model of chronic renal failure (CRF), and observed a native protective mechanism by which VC is reduced via the activation of Wnt1 and its transcriptional target ANKH inorganic pyrophosphate transport regulator (ANKH) gene. ANKH is an essential calcification inhibitor that effluxes inorganic pyrophosphate (PPi) from VSMCs to play an inhibitory role in VC. Vascular ANKH and plasma PPi were significantly downregulated in the rat model of CRF. The knockdown or inhibition of ANKH reversed the effect of Wnt1 on VC in VSMCs. Clinical analysis revealed low plasma levels of Wnt1 and PPi were associated with CKD in patients. Applying a Wnt/β-catenin signaling agonist can alleviate the progression of VC. This work reveals the ANKH regulation of Wnt1 in VSMCs is essential for blocking VC. Our findings may contribute to the development of medications that target Wnt signaling and/or ANKH to inhibit VC. Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chronic kidney disease (CKD) is not fully understood.AIMSWnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chronic kidney disease (CKD) is not fully understood.We used human vascular smooth muscle cells (VSMCs) and a rat model of chronic renal failure (CRF), and observed a native protective mechanism by which VC is reduced via the activation of Wnt1 and its transcriptional target ANKH inorganic pyrophosphate transport regulator (ANKH) gene. ANKH is an essential calcification inhibitor that effluxes inorganic pyrophosphate (PPi) from VSMCs to play an inhibitory role in VC. Vascular ANKH and plasma PPi were significantly downregulated in the rat model of CRF. The knockdown or inhibition of ANKH reversed the effect of Wnt1 on VC in VSMCs. Clinical analysis revealed low plasma levels of Wnt1 and PPi were associated with CKD in patients. Applying a Wnt/β-catenin signaling agonist can alleviate the progression of VC.METHODS AND RESULTSWe used human vascular smooth muscle cells (VSMCs) and a rat model of chronic renal failure (CRF), and observed a native protective mechanism by which VC is reduced via the activation of Wnt1 and its transcriptional target ANKH inorganic pyrophosphate transport regulator (ANKH) gene. ANKH is an essential calcification inhibitor that effluxes inorganic pyrophosphate (PPi) from VSMCs to play an inhibitory role in VC. Vascular ANKH and plasma PPi were significantly downregulated in the rat model of CRF. The knockdown or inhibition of ANKH reversed the effect of Wnt1 on VC in VSMCs. Clinical analysis revealed low plasma levels of Wnt1 and PPi were associated with CKD in patients. Applying a Wnt/β-catenin signaling agonist can alleviate the progression of VC.This work reveals the ANKH regulation of Wnt1 in VSMCs is essential for blocking VC. Our findings may contribute to the development of medications that target Wnt signaling and/or ANKH to inhibit VC.CONCLUSIONThis work reveals the ANKH regulation of Wnt1 in VSMCs is essential for blocking VC. Our findings may contribute to the development of medications that target Wnt signaling and/or ANKH to inhibit VC. |
Author | Xu, Ming-Jiang Feng, Lu Yin, Sen Cui, Zhong-Kai Chu, Yun-Chin Zhao, Ban Mao, Yonghui Wang, Cun-Yu Zhao, Yang Han, Duanyang Chen, Beidong Wang, Xian Zhao, Gexin |
Author_xml | – sequence: 1 givenname: Beidong orcidid: 0000-0002-0561-7873 surname: Chen fullname: Chen, Beidong organization: MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China – sequence: 2 givenname: Yang surname: Zhao fullname: Zhao, Yang organization: Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China – sequence: 3 givenname: Duanyang surname: Han fullname: Han, Duanyang organization: Shenzhen Key Laboratory of Spine Surgery, Department of Spine Surgery, Peking University Shenzhen Hospital, Shenzhen, China – sequence: 4 givenname: Ban surname: Zhao fullname: Zhao, Ban organization: Department of Nephrology, Beijing Hospital, Beijing, China – sequence: 5 givenname: Yonghui surname: Mao fullname: Mao, Yonghui organization: Department of Nephrology, Beijing Hospital, Beijing, China – sequence: 6 givenname: Zhong-Kai orcidid: 0000-0003-3112-9379 surname: Cui fullname: Cui, Zhong-Kai organization: Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China – sequence: 7 givenname: Yun-Chin surname: Chu fullname: Chu, Yun-Chin organization: Department of Statistics, North Carolina State University, USA – sequence: 8 givenname: Lu surname: Feng fullname: Feng, Lu organization: MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China – sequence: 9 givenname: Sen surname: Yin fullname: Yin, Sen organization: MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China – sequence: 10 givenname: Cun-Yu surname: Wang fullname: Wang, Cun-Yu organization: School of Dentistry, University of California, Los Angeles, USA – sequence: 11 givenname: Xian surname: Wang fullname: Wang, Xian organization: Department of Physiology and Pathophysiology, School of Basic Medical Science, Peking University Health Science Center, Beijing, China – sequence: 12 givenname: Ming-Jiang surname: Xu fullname: Xu, Ming-Jiang email: mingjiangxu@bjmu.edu.cn organization: Department of Physiology and Pathophysiology, School of Basic Medical Science, Peking University Health Science Center, Beijing, China – sequence: 13 givenname: Gexin orcidid: 0000-0003-2278-3432 surname: Zhao fullname: Zhao, Gexin email: zhaogexin@ucla.edu organization: Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31356809$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1v1DAQhi3Uim4LvwAJ-cglYWwncSLEoaroh6jgUsTRcpwJ9ZLYi-1U7L-vt9teemhPI3neZzTz-JgcOO-QkA8MSgas-bwut-vZmJID60qQJUD7hqwYdHXR1m11QFYAnBe85e0ROY5xDQBdJcRbciSYqJsWuhW5-e0So9bd2t6mSO90NMukA42z9-mWzks0E1KD00SNnowdrdHJekf7Ld0EP_tk3R96-uP7JcX_m4Ax5uY7cjjqKeL7x3pCfp1_uzm7LK5_XlydnV4XppIyFU2vK-xYxSTrmRmaRnKuORMDZ1Ulse5HwXnLqnYUve4HyM9NnZM1Mq0bBHFCPu3n5k3-LRiTmm3c7aod-iUqzhsJjEshc_TjY3TpZxzUJthZh616MpED3T5ggo8x4KiMTQ-npqDtpBionXW1Vg_W1c66Aqmy9cyKZ-zT-Jepr3sKs6I7i0FFY9EZHGxAk9Tg7Sv8l2e8mazL_zP9xe2r9D2WnbA8 |
CitedBy_id | crossref_primary_10_1038_s41598_020_77732_5 crossref_primary_10_3389_fcell_2020_586831 crossref_primary_10_1016_j_bone_2020_115243 crossref_primary_10_1016_j_lfs_2023_122309 crossref_primary_10_12677_ACM_2022_132169 crossref_primary_10_1016_j_acthis_2020_151551 crossref_primary_10_1080_0886022X_2022_2072337 crossref_primary_10_14336_AD_2021_1024 crossref_primary_10_2147_VHRM_S242685 crossref_primary_10_1016_j_bone_2020_115656 crossref_primary_10_3389_fgene_2022_838220 crossref_primary_10_1016_j_jacc_2023_01_044 crossref_primary_10_2139_ssrn_3894903 crossref_primary_10_2174_1567202619666220316115425 crossref_primary_10_1080_0886022X_2022_2114370 crossref_primary_10_1016_j_bone_2022_116525 |
Cites_doi | 10.1038/ki.2012.40 10.1038/ki.2015.194 10.5414/CN108547 10.1093/ckj/sfv077 10.1161/01.RES.0000216409.20863.e7 10.1038/ncomms10006 10.1359/jbmr.070714 10.1161/ATVBAHA.107.153668 10.1681/ASN.2004030203 10.1186/1471-2369-14-219 10.1186/s12858-016-0066-9 10.1161/01.ATV.0000154774.71187.f0 10.1074/jbc.M109.050534 10.1681/ASN.2013080818 10.1038/ki.2008.644 10.1111/j.1525-139X.2007.00300.x 10.1152/ajpcell.00419.2009 10.1111/j.1474-9726.2010.00661.x 10.1093/ndt/gfv111 10.1172/JCI24140 10.1126/science.1136370 10.2337/db14-0326 10.1096/fj.10-172981 10.1371/journal.pone.0019595 10.1093/ndt/gfv081 10.1016/j.bone.2009.09.006 10.1016/S0140-6736(01)06299-7 10.1161/ATVBAHA.110.204834 10.1126/science.289.5477.265 10.1093/ndt/gfg414 10.1016/j.atherosclerosis.2012.02.017 10.1016/j.devcel.2009.06.016 10.1681/ASN.2004080694 10.1093/ndt/gfp362 10.1152/ajpheart.01173.2003 10.1056/NEJM200005183422003 10.1038/nrcardio.2010.115 10.1161/CIRCRESAHA.117.306712 10.1006/dbio.1997.8552 10.1038/386078a0 10.1016/j.cell.2006.10.018 10.1016/j.regpep.2005.02.017 |
ContentType | Journal Article |
Copyright | 2019 Elsevier Ltd Copyright © 2019 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2019 Elsevier Ltd – notice: Copyright © 2019 Elsevier Ltd. All rights reserved. |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1016/j.yjmcc.2019.07.008 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1095-8584 |
EndPage | 21 |
ExternalDocumentID | 31356809 10_1016_j_yjmcc_2019_07_008 S0022282818311970 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABGSF ABJNI ABLJU ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO ADUVX AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HLW HMK HMO HVGLF HZ~ IHE J1W K-O KOM L7B LX2 M29 M41 MO0 N9A O-L O9- OAUVE OA~ OL0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SBG SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K WUQ X7M XPP Z5R ZGI ZMT ZU3 ~G- AACTN AAIAV ABLVK ABYKQ AEHWI AFKWA AHPSJ AJBFU AJOXV AMFUW DOVZS EFLBG LCYCR RIG SSU AAYXX AFCTW AGRNS CITATION NPM 7X8 |
ID | FETCH-LOGICAL-c477t-6ba4e914171b1cd66722a213d21447e5bf3228148f3babd021465b1c5e1aa6e03 |
IEDL.DBID | .~1 |
ISSN | 0022-2828 1095-8584 |
IngestDate | Mon Jul 21 09:23:39 EDT 2025 Wed Feb 19 02:30:17 EST 2025 Thu Apr 24 22:56:16 EDT 2025 Tue Jul 01 04:05:28 EDT 2025 Fri Feb 23 02:29:12 EST 2024 Tue Aug 26 17:11:59 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Vascular calcification Chronic kidney disease ANKH Wnt1 Vascular smooth muscle cells |
Language | English |
License | Copyright © 2019 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c477t-6ba4e914171b1cd66722a213d21447e5bf3228148f3babd021465b1c5e1aa6e03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-0561-7873 0000-0003-3112-9379 0000-0003-2278-3432 |
PMID | 31356809 |
PQID | 2267012737 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2267012737 pubmed_primary_31356809 crossref_citationtrail_10_1016_j_yjmcc_2019_07_008 crossref_primary_10_1016_j_yjmcc_2019_07_008 elsevier_sciencedirect_doi_10_1016_j_yjmcc_2019_07_008 elsevier_clinicalkey_doi_10_1016_j_yjmcc_2019_07_008 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October 2019 2019-10-00 20191001 |
PublicationDateYYYYMMDD | 2019-10-01 |
PublicationDate_xml | – month: 10 year: 2019 text: October 2019 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of molecular and cellular cardiology |
PublicationTitleAlternate | J Mol Cell Cardiol |
PublicationYear | 2019 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | O'Neill, Sigrist, McIntyre (bb0205) 2010 Jan; 25 Narisawa, Harmey, Yadav, O'Neill, Hoylaerts, Millan (bb0095) 2007 Nov; 22 Zhao, Xu, Zhao, Dai, Kong, Wilson (bb0105) 2012 Jul; 82 Luo, Ducy, McKee, Pinero, Loyer, Behringer (bb0160) 1997 Mar 6; 386 Qureshi, Olauson, Witasp, Haarhaus, Brandenburg, Wernerson (bb0050) 2015 Dec; 88 Cailotto, Sebillaud, Netter, Jouzeau, Bianchi (bb0165) 2010 Apr 2; 285 Shao, Cheng, Pingsterhaus, Charlton-Kachigian, Loewy, Towler (bb0030) 2005 May; 115 Cheng, Behrmann, Shao, Ramachandran, Krchma, Bello Arredondo (bb0035) 2014 Dec; 63 Fang, Ginsberg, Seifert, Agapova, Sugatani, Register (bb0045) 2014 Aug; 25 Kirkpantur, Balci, Turkvatan, Afsar (bb0055) 2015 Dec; 8 Zhu, Mackenzie, Millan, Farquharson, MacRae (bb0130) 2011; 6 Mani, Radhakrishnan, Wang, Mani, Nelson-Williams, Carew (bb0075) 2007 Mar 2; 315 Sage, Tintut, Demer (bb0080) 2010 Sep; 7 Giachelli (bb0125) 2009 May; 75 Foley, Murray, Li, Herzog, McBean, Eggers (bb0005) 2005 Feb; 16 Wang, Adhikari, Li, Hall (bb0090) 2004 Dec; 287 Fukuda, Sano, Kazetani, Yamamoto, Iwata, Matsui (bb0145) 2016 May 20; 17 Al-Aly, Shao, Lai, Huang, Cai, Behrmann (bb0180) 2007 Dec; 27 London, Guerin, Marchais, Metivier, Pannier, Adda (bb0020) 2003 Sep; 18 Johnson, Polewski, van Etten, Terkeltaub (bb0100) 2005 Apr; 25 Hruska, Saab, Mathew, Lund (bb0120) 2007 Jul-Aug; 20 Neven, Persy, Dauwe, De Schutter, De Broe, D'Haese (bb0040) 2010 Sep; 30 Lomashvili, Khawandi, O'Neill (bb0170) 2005 Aug; 16 Marchand, Atassi, Gaaya, Leprince, Le Feuvre, Soubrier (bb0190) 2011 Apr; 10 Goodman, Goldin, Kuizon, Yoon, Gales, Sider (bb0010) 2000 May 18; 342 Goliasch, Wiesbauer, Kastl, Katsaros, Blessberger, Maurer (bb0070) 2012 May; 222 Li, Yang, Giachelli (bb0135) 2006 Apr 14; 98 Schlieper, Schurgers, Brandenburg, Reutelingsperger, Floege (bb0025) 2016 Jan; 31 Albright, Stabach, Cao, Kavanagh, Mullen, Braddock (bb0200) 2015; 6 Ho, Johnson, Kingsley (bb0195) 2000 Jul 14; 289 Cheng, Ramachandran, Behrmann, Shao, Mead, Smith (bb0185) 2015 Jul 03; 117 McCullough, Sandberg, Dumler, Yanez (bb0015) 2004 Mar-Apr; 17 Clevers (bb0150) 2006 Nov 3; 127 Gherghe, Duan, Gong, Rojas, Klauber-Demore, Majesky (bb0065) 2011 Jun; 25 Roman-Garcia, Carrillo-Lopez, Fernandez-Martin, Naves-Diaz, Ruiz-Torres, Cannata-Andia (bb0210) 2010 Jan; 46 Prosdocimo, Wyler, Romani, O'Neill, Dubyak (bb0085) 2010 Mar; 298 Brandenburg, Kramann, Koos, Kruger, Schurgers, Muhlenbruch (bb0060) 2013 Oct 10; 14 Hedgepeth, Conrad, Zhang, Huang, Lee, Klein (bb0140) 1997 May 1; 185 Cai, Yu, Jiang, Jiang, Pan, Qi (bb0115) 2005 Jul 15; 129 Goodman (bb0175) 2001 Oct 6; 358 Morena, Jaussent, Dupuy, Bargnoux, Kuster, Chenine (bb0215) 2015 Aug; 30 Fu, Yang, Fan, Chen, Wu, Li (bb0110) 2016 Feb; 85 MacDonald, Tamai, He (bb0155) 2009 Jul; 17 Shao (10.1016/j.yjmcc.2019.07.008_bb0030) 2005; 115 Fang (10.1016/j.yjmcc.2019.07.008_bb0045) 2014; 25 Brandenburg (10.1016/j.yjmcc.2019.07.008_bb0060) 2013; 14 Hruska (10.1016/j.yjmcc.2019.07.008_bb0120) 2007; 20 McCullough (10.1016/j.yjmcc.2019.07.008_bb0015) 2004; 17 Marchand (10.1016/j.yjmcc.2019.07.008_bb0190) 2011; 10 Cheng (10.1016/j.yjmcc.2019.07.008_bb0035) 2014; 63 Lomashvili (10.1016/j.yjmcc.2019.07.008_bb0170) 2005; 16 MacDonald (10.1016/j.yjmcc.2019.07.008_bb0155) 2009; 17 Cailotto (10.1016/j.yjmcc.2019.07.008_bb0165) 2010; 285 Johnson (10.1016/j.yjmcc.2019.07.008_bb0100) 2005; 25 Albright (10.1016/j.yjmcc.2019.07.008_bb0200) 2015; 6 London (10.1016/j.yjmcc.2019.07.008_bb0020) 2003; 18 Gherghe (10.1016/j.yjmcc.2019.07.008_bb0065) 2011; 25 Prosdocimo (10.1016/j.yjmcc.2019.07.008_bb0085) 2010; 298 Narisawa (10.1016/j.yjmcc.2019.07.008_bb0095) 2007; 22 Goodman (10.1016/j.yjmcc.2019.07.008_bb0010) 2000; 342 Qureshi (10.1016/j.yjmcc.2019.07.008_bb0050) 2015; 88 Cheng (10.1016/j.yjmcc.2019.07.008_bb0185) 2015; 117 Morena (10.1016/j.yjmcc.2019.07.008_bb0215) 2015; 30 Fu (10.1016/j.yjmcc.2019.07.008_bb0110) 2016; 85 Li (10.1016/j.yjmcc.2019.07.008_bb0135) 2006; 98 Roman-Garcia (10.1016/j.yjmcc.2019.07.008_bb0210) 2010; 46 Clevers (10.1016/j.yjmcc.2019.07.008_bb0150) 2006; 127 Foley (10.1016/j.yjmcc.2019.07.008_bb0005) 2005; 16 Neven (10.1016/j.yjmcc.2019.07.008_bb0040) 2010; 30 Hedgepeth (10.1016/j.yjmcc.2019.07.008_bb0140) 1997; 185 Ho (10.1016/j.yjmcc.2019.07.008_bb0195) 2000; 289 Kirkpantur (10.1016/j.yjmcc.2019.07.008_bb0055) 2015; 8 Cai (10.1016/j.yjmcc.2019.07.008_bb0115) 2005; 129 Fukuda (10.1016/j.yjmcc.2019.07.008_bb0145) 2016; 17 Luo (10.1016/j.yjmcc.2019.07.008_bb0160) 1997; 386 O'Neill (10.1016/j.yjmcc.2019.07.008_bb0205) 2010; 25 Wang (10.1016/j.yjmcc.2019.07.008_bb0090) 2004; 287 Schlieper (10.1016/j.yjmcc.2019.07.008_bb0025) 2016; 31 Zhu (10.1016/j.yjmcc.2019.07.008_bb0130) 2011; 6 Al-Aly (10.1016/j.yjmcc.2019.07.008_bb0180) 2007; 27 Goliasch (10.1016/j.yjmcc.2019.07.008_bb0070) 2012; 222 Sage (10.1016/j.yjmcc.2019.07.008_bb0080) 2010; 7 Goodman (10.1016/j.yjmcc.2019.07.008_bb0175) 2001; 358 Mani (10.1016/j.yjmcc.2019.07.008_bb0075) 2007; 315 Zhao (10.1016/j.yjmcc.2019.07.008_bb0105) 2012; 82 Giachelli (10.1016/j.yjmcc.2019.07.008_bb0125) 2009; 75 |
References_xml | – volume: 16 start-page: 489 year: 2005 Feb end-page: 495 ident: bb0005 article-title: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999 publication-title: J. Am. Soc. Nephrol. – volume: 222 start-page: 251 year: 2012 May end-page: 256 ident: bb0070 article-title: Premature myocardial infarction is associated with low serum levels of Wnt-1 publication-title: Atherosclerosis. – volume: 17 start-page: 9 year: 2016 May 20 ident: bb0145 article-title: Tubulin is a molecular target of the Wnt-activating chemical probe publication-title: BMC Biochem. – volume: 63 start-page: 4326 year: 2014 Dec end-page: 4337 ident: bb0035 article-title: Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets publication-title: Diabetes. – volume: 25 start-page: 187 year: 2010 Jan end-page: 191 ident: bb0205 article-title: Plasma pyrophosphate and vascular calcification in chronic kidney disease publication-title: Nephrol. Dial. Transplant. – volume: 25 start-page: 1760 year: 2014 Aug end-page: 1773 ident: bb0045 article-title: CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder publication-title: J. Am. Soc. Nephrol. – volume: 88 start-page: 1356 year: 2015 Dec end-page: 1364 ident: bb0050 article-title: Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification publication-title: Kidney Int. – volume: 358 start-page: 1115 year: 2001 Oct 6 end-page: 1116 ident: bb0175 article-title: Vascular calcification in chronic renal failure publication-title: Lancet. – volume: 287 start-page: H2376 year: 2004 Dec end-page: H2383 ident: bb0090 article-title: LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 22 start-page: 1700 year: 2007 Nov end-page: 1710 ident: bb0095 article-title: Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification publication-title: J. Bone Miner. Res. – volume: 30 start-page: 1741 year: 2010 Sep end-page: 1750 ident: bb0040 article-title: Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 30 start-page: 1345 year: 2015 Aug end-page: 1356 ident: bb0215 article-title: Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications publication-title: Nephrol. Dial. Transplant. – volume: 315 start-page: 1278 year: 2007 Mar 2 end-page: 1282 ident: bb0075 article-title: LRP6 mutation in a family with early coronary disease and metabolic risk factors publication-title: Science. – volume: 46 start-page: 121 year: 2010 Jan end-page: 128 ident: bb0210 article-title: High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression publication-title: Bone. – volume: 185 start-page: 82 year: 1997 May 1 end-page: 91 ident: bb0140 article-title: Activation of the Wnt signaling pathway: a molecular mechanism for lithium action publication-title: Dev. Biol. – volume: 17 start-page: 205 year: 2004 Mar-Apr end-page: 215 ident: bb0015 article-title: Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review publication-title: J Nephrol. – volume: 16 start-page: 2495 year: 2005 Aug end-page: 2500 ident: bb0170 article-title: Reduced plasma pyrophosphate levels in hemodialysis patients publication-title: J. Am. Soc. Nephrol. – volume: 298 start-page: C702 year: 2010 Mar end-page: C713 ident: bb0085 article-title: Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia publication-title: Am. J. Phys. Cell Physiol. – volume: 20 start-page: 309 year: 2007 Jul-Aug end-page: 315 ident: bb0120 article-title: Renal osteodystrophy, phosphate homeostasis, and vascular calcification publication-title: Semin. Dial. – volume: 85 start-page: 92 year: 2016 Feb end-page: 100 ident: bb0110 article-title: Prediction of all-cause death in hemodialysis patients using elevated postdialysis pulse wave velocity publication-title: Clin. Nephrol. – volume: 117 start-page: 142 year: 2015 Jul 03 end-page: 156 ident: bb0185 article-title: Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals publication-title: Circ. Res. – volume: 18 start-page: 1731 year: 2003 Sep end-page: 1740 ident: bb0020 article-title: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality publication-title: Nephrol. Dial. Transplant. – volume: 82 start-page: 34 year: 2012 Jul end-page: 44 ident: bb0105 article-title: Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression publication-title: Kidney Int. – volume: 127 start-page: 469 year: 2006 Nov 3 end-page: 480 ident: bb0150 article-title: Wnt/beta-catenin signaling in development and disease publication-title: Cell. – volume: 285 start-page: 10572 year: 2010 Apr 2 end-page: 10582 ident: bb0165 article-title: The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocyte publication-title: J. Biol. Chem. – volume: 6 year: 2015 ident: bb0200 article-title: ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy publication-title: Nat. Commun. – volume: 31 start-page: 31 year: 2016 Jan end-page: 39 ident: bb0025 article-title: Vascular calcification in chronic kidney disease: an update publication-title: Nephrol. Dial. Transplant. – volume: 6 year: 2011 ident: bb0130 article-title: The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells publication-title: PLoS One – volume: 17 start-page: 9 year: 2009 Jul end-page: 26 ident: bb0155 article-title: Wnt/beta-catenin signaling: components, mechanisms, and diseases publication-title: Dev. Cell – volume: 98 start-page: 905 year: 2006 Apr 14 end-page: 912 ident: bb0135 article-title: Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification publication-title: Circ. Res. – volume: 25 start-page: 1836 year: 2011 Jun end-page: 1843 ident: bb0065 article-title: Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF-dependent manner publication-title: FASEB J. – volume: 75 start-page: 890 year: 2009 May end-page: 897 ident: bb0125 article-title: The emerging role of phosphate in vascular calcification publication-title: Kidney Int. – volume: 115 start-page: 1210 year: 2005 May end-page: 1220 ident: bb0030 article-title: Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals publication-title: J. Clin. Invest. – volume: 8 start-page: 737 year: 2015 Dec end-page: 743 ident: bb0055 article-title: Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients publication-title: Clin. Kidney J. – volume: 342 start-page: 1478 year: 2000 May 18 end-page: 1483 ident: bb0010 article-title: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis publication-title: N. Engl. J. Med. – volume: 27 start-page: 2589 year: 2007 Dec end-page: 2596 ident: bb0180 article-title: Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr−/− mice publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 289 start-page: 265 year: 2000 Jul 14 end-page: 270 ident: bb0195 article-title: Role of the mouse ank gene in control of tissue calcification and arthritis publication-title: Science. – volume: 14 start-page: 219 year: 2013 Oct 10 ident: bb0060 article-title: Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study publication-title: BMC Nephrol. – volume: 386 start-page: 78 year: 1997 Mar 6 end-page: 81 ident: bb0160 article-title: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein publication-title: Nature. – volume: 129 start-page: 125 year: 2005 Jul 15 end-page: 132 ident: bb0115 article-title: Adrenomedullin(27-52) inhibits vascular calcification in rats publication-title: Regul. Pept. – volume: 10 start-page: 220 year: 2011 Apr end-page: 232 ident: bb0190 article-title: The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans publication-title: Aging Cell – volume: 7 start-page: 528 year: 2010 Sep end-page: 536 ident: bb0080 article-title: Regulatory mechanisms in vascular calcification publication-title: Nat. Rev. Cardiol. – volume: 25 start-page: 686 year: 2005 Apr end-page: 691 ident: bb0100 article-title: Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1−/− mice publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 82 start-page: 34 issue: 1 year: 2012 ident: 10.1016/j.yjmcc.2019.07.008_bb0105 article-title: Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression publication-title: Kidney Int. doi: 10.1038/ki.2012.40 – volume: 88 start-page: 1356 issue: 6 year: 2015 ident: 10.1016/j.yjmcc.2019.07.008_bb0050 article-title: Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification publication-title: Kidney Int. doi: 10.1038/ki.2015.194 – volume: 85 start-page: 92 issue: 2 year: 2016 ident: 10.1016/j.yjmcc.2019.07.008_bb0110 article-title: Prediction of all-cause death in hemodialysis patients using elevated postdialysis pulse wave velocity publication-title: Clin. Nephrol. doi: 10.5414/CN108547 – volume: 8 start-page: 737 issue: 6 year: 2015 ident: 10.1016/j.yjmcc.2019.07.008_bb0055 article-title: Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients publication-title: Clin. Kidney J. doi: 10.1093/ckj/sfv077 – volume: 98 start-page: 905 issue: 7 year: 2006 ident: 10.1016/j.yjmcc.2019.07.008_bb0135 article-title: Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification publication-title: Circ. Res. doi: 10.1161/01.RES.0000216409.20863.e7 – volume: 6 year: 2015 ident: 10.1016/j.yjmcc.2019.07.008_bb0200 article-title: ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy publication-title: Nat. Commun. doi: 10.1038/ncomms10006 – volume: 22 start-page: 1700 issue: 11 year: 2007 ident: 10.1016/j.yjmcc.2019.07.008_bb0095 article-title: Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification publication-title: J. Bone Miner. Res. doi: 10.1359/jbmr.070714 – volume: 27 start-page: 2589 issue: 12 year: 2007 ident: 10.1016/j.yjmcc.2019.07.008_bb0180 article-title: Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr−/− mice publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.107.153668 – volume: 16 start-page: 489 issue: 2 year: 2005 ident: 10.1016/j.yjmcc.2019.07.008_bb0005 article-title: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999 publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2004030203 – volume: 14 start-page: 219 year: 2013 ident: 10.1016/j.yjmcc.2019.07.008_bb0060 article-title: Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study publication-title: BMC Nephrol. doi: 10.1186/1471-2369-14-219 – volume: 17 start-page: 9 issue: 1 year: 2016 ident: 10.1016/j.yjmcc.2019.07.008_bb0145 article-title: Tubulin is a molecular target of the Wnt-activating chemical probe publication-title: BMC Biochem. doi: 10.1186/s12858-016-0066-9 – volume: 25 start-page: 686 issue: 4 year: 2005 ident: 10.1016/j.yjmcc.2019.07.008_bb0100 article-title: Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1−/− mice publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.0000154774.71187.f0 – volume: 285 start-page: 10572 issue: 14 year: 2010 ident: 10.1016/j.yjmcc.2019.07.008_bb0165 article-title: The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocyte publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109.050534 – volume: 25 start-page: 1760 issue: 8 year: 2014 ident: 10.1016/j.yjmcc.2019.07.008_bb0045 article-title: CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2013080818 – volume: 75 start-page: 890 issue: 9 year: 2009 ident: 10.1016/j.yjmcc.2019.07.008_bb0125 article-title: The emerging role of phosphate in vascular calcification publication-title: Kidney Int. doi: 10.1038/ki.2008.644 – volume: 20 start-page: 309 issue: 4 year: 2007 ident: 10.1016/j.yjmcc.2019.07.008_bb0120 article-title: Renal osteodystrophy, phosphate homeostasis, and vascular calcification publication-title: Semin. Dial. doi: 10.1111/j.1525-139X.2007.00300.x – volume: 298 start-page: C702 issue: 3 year: 2010 ident: 10.1016/j.yjmcc.2019.07.008_bb0085 article-title: Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia publication-title: Am. J. Phys. Cell Physiol. doi: 10.1152/ajpcell.00419.2009 – volume: 10 start-page: 220 issue: 2 year: 2011 ident: 10.1016/j.yjmcc.2019.07.008_bb0190 article-title: The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans publication-title: Aging Cell doi: 10.1111/j.1474-9726.2010.00661.x – volume: 31 start-page: 31 issue: 1 year: 2016 ident: 10.1016/j.yjmcc.2019.07.008_bb0025 article-title: Vascular calcification in chronic kidney disease: an update publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfv111 – volume: 115 start-page: 1210 issue: 5 year: 2005 ident: 10.1016/j.yjmcc.2019.07.008_bb0030 article-title: Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals publication-title: J. Clin. Invest. doi: 10.1172/JCI24140 – volume: 315 start-page: 1278 issue: 5816 year: 2007 ident: 10.1016/j.yjmcc.2019.07.008_bb0075 article-title: LRP6 mutation in a family with early coronary disease and metabolic risk factors publication-title: Science. doi: 10.1126/science.1136370 – volume: 63 start-page: 4326 issue: 12 year: 2014 ident: 10.1016/j.yjmcc.2019.07.008_bb0035 article-title: Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets publication-title: Diabetes. doi: 10.2337/db14-0326 – volume: 25 start-page: 1836 issue: 6 year: 2011 ident: 10.1016/j.yjmcc.2019.07.008_bb0065 article-title: Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF-dependent manner publication-title: FASEB J. doi: 10.1096/fj.10-172981 – volume: 6 issue: 5 year: 2011 ident: 10.1016/j.yjmcc.2019.07.008_bb0130 article-title: The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells publication-title: PLoS One doi: 10.1371/journal.pone.0019595 – volume: 30 start-page: 1345 issue: 8 year: 2015 ident: 10.1016/j.yjmcc.2019.07.008_bb0215 article-title: Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfv081 – volume: 46 start-page: 121 issue: 1 year: 2010 ident: 10.1016/j.yjmcc.2019.07.008_bb0210 article-title: High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression publication-title: Bone. doi: 10.1016/j.bone.2009.09.006 – volume: 358 start-page: 1115 issue: 9288 year: 2001 ident: 10.1016/j.yjmcc.2019.07.008_bb0175 article-title: Vascular calcification in chronic renal failure publication-title: Lancet. doi: 10.1016/S0140-6736(01)06299-7 – volume: 30 start-page: 1741 issue: 9 year: 2010 ident: 10.1016/j.yjmcc.2019.07.008_bb0040 article-title: Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.110.204834 – volume: 289 start-page: 265 issue: 5477 year: 2000 ident: 10.1016/j.yjmcc.2019.07.008_bb0195 article-title: Role of the mouse ank gene in control of tissue calcification and arthritis publication-title: Science. doi: 10.1126/science.289.5477.265 – volume: 18 start-page: 1731 issue: 9 year: 2003 ident: 10.1016/j.yjmcc.2019.07.008_bb0020 article-title: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfg414 – volume: 222 start-page: 251 issue: 1 year: 2012 ident: 10.1016/j.yjmcc.2019.07.008_bb0070 article-title: Premature myocardial infarction is associated with low serum levels of Wnt-1 publication-title: Atherosclerosis. doi: 10.1016/j.atherosclerosis.2012.02.017 – volume: 17 start-page: 9 issue: 1 year: 2009 ident: 10.1016/j.yjmcc.2019.07.008_bb0155 article-title: Wnt/beta-catenin signaling: components, mechanisms, and diseases publication-title: Dev. Cell doi: 10.1016/j.devcel.2009.06.016 – volume: 16 start-page: 2495 issue: 8 year: 2005 ident: 10.1016/j.yjmcc.2019.07.008_bb0170 article-title: Reduced plasma pyrophosphate levels in hemodialysis patients publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2004080694 – volume: 25 start-page: 187 issue: 1 year: 2010 ident: 10.1016/j.yjmcc.2019.07.008_bb0205 article-title: Plasma pyrophosphate and vascular calcification in chronic kidney disease publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfp362 – volume: 287 start-page: H2376 issue: 6 year: 2004 ident: 10.1016/j.yjmcc.2019.07.008_bb0090 article-title: LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.01173.2003 – volume: 342 start-page: 1478 issue: 20 year: 2000 ident: 10.1016/j.yjmcc.2019.07.008_bb0010 article-title: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200005183422003 – volume: 7 start-page: 528 issue: 9 year: 2010 ident: 10.1016/j.yjmcc.2019.07.008_bb0080 article-title: Regulatory mechanisms in vascular calcification publication-title: Nat. Rev. Cardiol. doi: 10.1038/nrcardio.2010.115 – volume: 117 start-page: 142 issue: 2 year: 2015 ident: 10.1016/j.yjmcc.2019.07.008_bb0185 article-title: Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.117.306712 – volume: 185 start-page: 82 issue: 1 year: 1997 ident: 10.1016/j.yjmcc.2019.07.008_bb0140 article-title: Activation of the Wnt signaling pathway: a molecular mechanism for lithium action publication-title: Dev. Biol. doi: 10.1006/dbio.1997.8552 – volume: 386 start-page: 78 issue: 6620 year: 1997 ident: 10.1016/j.yjmcc.2019.07.008_bb0160 article-title: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein publication-title: Nature. doi: 10.1038/386078a0 – volume: 17 start-page: 205 issue: 2 year: 2004 ident: 10.1016/j.yjmcc.2019.07.008_bb0015 article-title: Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review publication-title: J Nephrol. – volume: 127 start-page: 469 issue: 3 year: 2006 ident: 10.1016/j.yjmcc.2019.07.008_bb0150 article-title: Wnt/beta-catenin signaling in development and disease publication-title: Cell. doi: 10.1016/j.cell.2006.10.018 – volume: 129 start-page: 125 issue: 1–3 year: 2005 ident: 10.1016/j.yjmcc.2019.07.008_bb0115 article-title: Adrenomedullin(27-52) inhibits vascular calcification in rats publication-title: Regul. Pept. doi: 10.1016/j.regpep.2005.02.017 |
SSID | ssj0009433 |
Score | 2.381828 |
Snippet | Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 10 |
SubjectTerms | ANKH Chronic kidney disease Vascular calcification Vascular smooth muscle cells Wnt1 |
Title | Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0022282818311970 https://dx.doi.org/10.1016/j.yjmcc.2019.07.008 https://www.ncbi.nlm.nih.gov/pubmed/31356809 https://www.proquest.com/docview/2267012737 |
Volume | 135 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwEA9DQXwRv51fRPDR6tKkyfo4RJmO7UEUfQtNm2qH64brQF_8271L24ngB_hUWnK0vUvuLrnf3RFyzGCF2dQYD4yJ9URgQ8-ApfeEBeMZWdUyMSY49weyeyeuH4KHBjmvc2EQVlnp_lKnO21dPTmruHk2yTLM8cXTC6xmxDEWhvt2IRTO8tP3T5hHKMp28ohax9F15SGH8XobjmKsY8hCV8ETe0x-b51-8j6dFbpcJSuV-0g75ReukYbN18lSvwqQb5Db-7xgNMufMpMVU1rjTOl0NAaR0NFsCmQUT-spCMfh8ZxoqHmjkxKZlz_SzqDXpfa1wsjmm-Tu8uL2vOtVjRO8WChVeNJEwoZMMMUMixMple9HPuMJ1kdTNjApLOM2bIRSbiKTuObeAYwMLIsiaVt8iyzk49zuEAreTcAsl0Ylvkh4GvlJCk-kSZPYj9u8SfyaYTquqopjc4tnXcPHhtpxWSOXdQuj3e0mOZkTTcqiGr8PF7UkdJ0vChpOg9L_nUzOyb5Mqb8Jj2pxa1hsKJMot-PZVIOvqjBWz1WTbJfzYP4DnPFAtlvh7n9fu0eW8a5ECu6TheJlZg_A4ynMoZvSh2Sxc9XrDvDau7nvfQBAqgC9 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4lkWChgJboTGj9ibQw8VUG3Z7p62ojcTJw6kYrMrkhXshT_VP9gZx1mEBEVC6tXx5DEez4wz38wQ8pLBDnOltREYExfJxKWRBUsfSQfGM3M6tjkmOE-manQiP5wmp1vkvM-FQVhl0P2dTvfaOozsBW7uLasKc3zx7wVWMxIYC4sDsnLs1t_h3NbsH72DRX7F-eH72dtRFFoLRLnUuo2UzaRLmWSaWZYXSmnOM85EgRXEtEtsCYI-hKNCKWxmC9_-OoGZiWNZplws4L7XyHUJ6gLbJrz5-QtXksqufz3C5PH1-lJHHlS2PpvnWDiRpb5kKDa1_LM5_Ju7683e4R1yO_ir9KBjyV2y5ep75MYkROTvk9nHumW0qr9Utmob2gNbaTNfgAzQ-aoBMorhAQrS4AGAXhaoXdNlBwWsP9OD6XhE3Y8Ayq0fkJMrYedDsl0vaveIUHCnEuaEsrrgshBlxosSRpQti5znQzEgvGeYyUMZc-ym8dX0eLUz47lskMsmxvD6cEBeb4iWXRWPy6fLfiVMn6AKKtWAlbmcTG3IfpPhfxO-6JfbwO7GNclqt1g1BpxjjeAAoQdkp5ODzQcIJhI1jNPH__vY5-TmaDY5NsdH0_ETcguvdDDFXbLdflu5p-ButfaZF29KPl31froAgJM5cA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Wnt1+inhibits+vascular+smooth+muscle+cell+calcification+by+promoting+ANKH+expression&rft.jtitle=Journal+of+molecular+and+cellular+cardiology&rft.au=Chen%2C+Beidong&rft.au=Zhao%2C+Yang&rft.au=Han%2C+Duanyang&rft.au=Zhao%2C+Ban&rft.date=2019-10-01&rft.pub=Elsevier+Ltd&rft.issn=0022-2828&rft.volume=135&rft.spage=10&rft.epage=21&rft_id=info:doi/10.1016%2Fj.yjmcc.2019.07.008&rft.externalDocID=S0022282818311970 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2828&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2828&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2828&client=summon |